- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Relief Therapeutics Holding SA (0QKQ)
6.20
+4.59(+285.09%)
Real-time Data
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.15
6.20
52 wk Range
1.06
6.20
0QKQ Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Assess today's live Relief Therapeutics Holding SA (RLFB) share price, performance and insights using our live Switzerland: RLFB stock exchange data.
Analyse the historical data and Relief Therapeutics Holding SA share price performance charts on this page. Our technical summary section provides analysis on Relief Therapeutics share price buy/sell indicators using real-time data (or discuss the Relief Therapeutics (RLFB) stock price today with other investors in the Relief Therapeutics SIX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SIX RLFB share price (ISIN: CH1251125998) to enhance your trading decisions with our free investment tools and resources.
What Is the Relief Therapeutics Holding SA Share Price Today?
The Relief Therapeutics share price today is 6.20.
What Is the Stock Symbol for Relief Therapeutics Holding SA
The stock symbol (or 'ticker') for Relief Therapeutics Holding SA is "RLFB."
What Stock Exchange Does Relief Therapeutics Holding SA Trade On?
Relief Therapeutics Holding SA is listed and trades on the Switzerland stock exchange.
Is Relief Therapeutics Holding SA a Good Stock to Buy?
Determining whether Relief Therapeutics Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Relief Therapeutics Holding SA share price performance charts on this page. Our technical summary section provides analysis on Relief Therapeutics share price buy/sell indicators using real-time data (or discuss the Relief Therapeutics (RLFB) stock price today with other investors in the Relief Therapeutics SIX share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current SIX RLFB share price (ISIN: CH1251125998) to enhance your trading decisions with our free investment tools and resources.
What Is the Relief Therapeutics Holding SA Share Price Today?
The Relief Therapeutics share price today is 6.20.
What Is the Stock Symbol for Relief Therapeutics Holding SA
The stock symbol (or 'ticker') for Relief Therapeutics Holding SA is "RLFB."
What Stock Exchange Does Relief Therapeutics Holding SA Trade On?
Relief Therapeutics Holding SA is listed and trades on the Switzerland stock exchange.
Is Relief Therapeutics Holding SA a Good Stock to Buy?
Determining whether Relief Therapeutics Holding SA—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4.156.20
52 wk Range
1.066.20
Unlock0QKQ Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Relief Therapeutics Holding SA Company Profile
Relief Therapeutics Holding SA, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of rare metabolic, dermatological, and pulmonary diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting; OLPRUVA, a sodium phenylbutyrate for the treatment of urea cycle disorders, and maple syrup urine disease; and PKU GOLIKE for for the dietary management of phenylketonuria. It also develops TYR GOLIKE, that has completed Phase III clinical trial to treat Tyrosinemia; and RLF-100, a synthetic form of vasoactive intestinal peptide (VIP), that is in Phase II clinical trial for the treatment of acute respiratory distress syndrome (ARDS) associated with COVID-19 related ARDS and in preclinical trial to treat pulmonary sarcoidosis, checkpoint inhibitor-induced pneumonitis, and chronic berylliosis. In addition, the company also develops HCU GOLIKE, which is in Phase I clinical trial for the treatment of Homocystinuria; and RLF-TD011, a hypochlorous acid topical sprayable solution, that is in Phase I clinical trial to treat wound colonization, reduce local inflammation, alleviate symptoms, and hasten wound healing in epidermolysis bullosa. Further, it is developing RLF-OD32, which is in Phase I clinical trial for the treatment of patients with phenylketonuria; and. Relief Therapeutics Holding SA was founded in 2013 and is based in Geneva, Switzerland.
Compare 0QKQ to Peers and Sector
Metrics to compare | 0QKQ | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship0QKQPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.1x | −1.0x | −0.6x | |
PEG Ratio | −0.02 | −0.01 | 0.00 | |
Price/Book | 1.1x | 1.3x | 2.6x | |
Price / LTM Sales | 6.0x | 4.1x | 3.3x | |
Upside (Analyst Target) | - | 125.1% | 44.5% | |
Fair Value Upside | Unlock | 17.5% | 6.0% | Unlock |
People Also Watch
FAQ
What Is the Relief Therapeutics (0QKQ) Stock Price Today?
The Relief Therapeutics stock price today is 6.20
What Stock Exchange Does Relief Therapeutics Trade On?
Relief Therapeutics is listed and trades on the London stock exchange.
What Is the Stock Symbol for Relief Therapeutics?
The stock symbol for Relief Therapeutics is "0QKQ."
What Is the Relief Therapeutics Market Cap?
As of today, Relief Therapeutics market cap is 66.46M.
What is Relief Therapeutics Earnings Per Share?
The Relief Therapeutics EPS is -3.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.